Nonpartisan civic infrastructure

H.R. 7640

BillFederalHouseIntroduced

To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as orphan drugs).

About This Bill

Introduced

Congress

117th (2021–2023)

Introduced

May 3, 2022

Sponsor

Rep. Gus BilirakisR

Cosponsors (1)

1D 0R

View PDF ↗

Summary Full Text Comments Annotations

Public Comments (0)

No comments yet. Be the first to weigh in from the Take Action box.

Take Action

Your position

Add a comment

to comment on this bill.

Annotate the text

Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.